Oncology Ward Five at Guangzhou Xinshi Hospital | Generated by AI

Home 2026.04

Question: How does Professor Luo Pengfei (罗鹏飞) and the Oncology Ward 5 (肿瘤五科) relate to Guangzhou Xinshi Hospital — is it a subsidiary department inside the hospital?

Answer:

Relationship Between Prof. Luo Pengfei, Oncology Ward 5, and Guangzhou Xinshi Hospital

Short answer: Yes — 肿瘤五科 (Oncology Department, Ward 5) is an internal clinical department within Guangzhou Xinshi Hospital, and Prof. Luo Pengfei is its leading expert physician. It is not a separate or subsidiary organization.

1. Oncology Ward 5 is a Department Inside the Hospital

The hospital’s official department listing includes “肿瘤科五区” (Oncology Ward 5) alongside many other departments such as Cardiology, Neurology, Obstetrics, ICU, and more — all under the same hospital roof. Prof. Luo Pengfei is explicitly listed as the key expert of 肿瘤科五区 on the hospital’s own homepage.

Oncology Ward 5 is described as a key oncology minimally invasive specialty department of Guangdong Pharmaceutical University’s Third Affiliated Hospital (which is the same institution as Guangzhou Xinshi Hospital). It has a designated capacity of 40 beds, and has established the “Professor Luo Pengfei Famous Physician Studio” within it.

2. Who is Professor Luo Pengfei (罗鹏飞)?

Prof. Luo Pengfei is a renowned expert in tumor interventional radiology, the founder of the “Luo Pengfei Formula Cancer Treatment Method” (罗鹏飞程式肿瘤诊疗法), Vice-Director of the Guangdong Cancer Prevention and Treatment Center, former Director of the Imaging Intervention Center at Guangdong Provincial People’s Hospital, a recipient of the State Council Special Government Allowance, a member of the Central Healthcare Bureau consultation expert group, Vice-Chairman of the Interventional Radiology Society of the Chinese Medical Association, and Vice-Chairman of the Tumor Interventional Diagnosis and Treatment Committee of the China Anti-Cancer Association.

Prof. Luo joined Guangzhou Xinshi Hospital’s Oncology Ward 5 as his third career practice site, after working at Guangdong Provincial People’s Hospital and Zhuhai People’s Hospital. On November 5, 2019, he and his student Wang Jian co-founded the “Tumor Interventional Research Team” within Ward 5, specializing in vascular tumor comprehensive minimally invasive disciplines.

3. What Does the Team Do There?

The department’s specialty medical technologies include minimally invasive interventional ablation techniques for liver cancer, lung cancer, gastric cancer, breast cancer, colorectal cancer, esophageal cancer, malignant lymphoma, urological tumors, gynecological tumors, head and neck tumors, intracranial tumors, bone tumors, and metastatic cancers. It also carries out procedures such as comprehensive tumor vascular intervention, particle implantation, argon-helium knife cryoablation, microwave radiofrequency ablation, photodynamic therapy, thermal perfusion therapy, and peripheral vascular intervention.

The team currently completes over 1,000 cancer minimally invasive interventional procedures per year, with the scope of cases and surgical complexity continuously expanding.

4. International Patent Achievement

In October 2022, the “Luo Pengfei Formula — Programmatic Inactivation of Tumor Biological Activity Standardized Diagnosis and Treatment” method, developed by the Oncology Ward 5 research team at Guangzhou Xinshi Hospital, was granted a patent by the Luxembourg Government Intellectual Property Office (Patent No. LU501835). This is the first internationally patented therapy in the domestic tumor interventional discipline.

Summary Table

Item Detail
Nature of 肿瘤五科 Internal clinical department of Guangzhou Xinshi Hospital
Also known as 肿瘤科五区 / Oncology Ward 5
Department beds 40 beds
Key figure Prof. Luo Pengfei (罗鹏飞), Chief Physician
Team name 罗鹏飞·王健 Tumor Interventional Research Team
Specialty Minimally invasive interventional oncology
Annual procedures 1,000–1,500+ cases
Notable achievement International patent (Luxembourg, LU501835, 2022)

References:

Back Donate